Codexis, Inc. CDXS
Set alert
1.19 USD -0.03 -2.46%
At close · Oct 30
1.19 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.17 Day range 1.24
0.98 52-week range 2.85
- YTD
- -26.99%
- 1 year
- -49.58%
- Open
- 1.20
- Prev close
- 1.22
- Mkt cap
- 130.31M
- Vol
- 789.47K
- Avg vol
- 939.70K
- EPS
- -0.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.17
- High
- 1.24
- Forward P/E
- -7.14
- Beta
- 2.07
- Short ratio
- 2.56
- Inst. own
- 79.79%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 4.19
- 200-d avg
- 3.43
- 1y target
- 7.17
2Y chart
Events in this range
- Oct 31, 2024Earnings: -0.29; estimate -0.25; surprise -16%
- Nov 4, 2024Rating: Benchmark · — → Hold
- Nov 15, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
- Nov 22, 2024Rating: Cantor Fitzgerald · Overweight → Overweight
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 29, 2026 | 2 days ago |
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 11, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 8, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 11, 2026 | 2 months ago |
| RSI: Oversold | Aug 7, 2026 | 2 months ago |
| RSI: Oversold | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bearish | Jun 9, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 5, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 4 months ago |
| MACD: Sell Signal | May 1, 2026 | 6 months ago |
| RSI: Overbought | Apr 24, 2026 | 6 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| RSI: Overbought | Apr 8, 2026 | 6 months ago |
| SMA: Bullish | Mar 12, 2026 | 7 months ago |
| RSI: Overbought | Mar 12, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 4, 2026 | 8 months ago |
| RSI: Oversold | Mar 3, 2026 | 8 months ago |
| RSI: Oversold | Feb 27, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 23, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 16, 2026 | 9 months ago |
| SMA: Bullish | Jan 14, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| RSI: Oversold | Nov 20, 2025 | 11 months ago |
| RSI: Oversold | Nov 13, 2025 | 11 months ago |
| RSI: Oversold | Nov 6, 2025 | 11 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 28, 2025 | 1 year ago |
| SMA: Bullish | Oct 24, 2025 | 1 year ago |
| SMA: Bearish | Oct 22, 2025 | 1 year ago |
| SMA: Bullish | Oct 15, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bearish | Oct 7, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Aug 25, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 19, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| SMA: Bullish | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 23, 2025 | 1 year ago |
| SMA: Bearish | Jun 20, 2025 | 1 year ago |
| SMA: Bullish | Jun 18, 2025 | 1 year ago |
| SMA: Bearish | Jun 12, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | May 29, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 22, 2025 | 1 year ago |
| SMA: Bullish | May 15, 2025 | 1 year ago |
| SMA: Bearish | May 14, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 11, 2025 | 1 year ago |
| RSI: Oversold | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Feb 28, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 27, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 26, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 15, 2025 | 1 year ago |
Key statistics
- Market cap
- 401.19M
- Enterprise value
- 381.27M
- Trailing P/E
- 0.00
- Forward P/E
- -7.14
- PEG ratio
- 0.00
- Price / sales
- 6.23
- Price / book
- 5.47
- EPS (TTM)
- -0.88
- Beta
- 2.07
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -96.35%
- Revenue (TTM)
- 64.45M
- Revenue growth
- 38.30%
- Free cash flow
- -8.12M
- Total cash
- 90.25M
- Total debt
- 41.85M
- Return on equity
- -75.31%
- Shares outstanding
- 81.38M
- Short % of float
- 2.36%
- 50-day average
- 4.19
- 200-day average
- 3.43
Analyst view
Consensus: none
Price target (mean) 7.17 +502.2% upside
Now 1.19
- Target (low)
- 3.00
- Target (mean)
- 7.17
- Target (high)
- 11.00
Ratings (0m) 7 5 buy · 2 hold · 0 sell
- Strong buy1
- Buy4
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.02167.
Financials — quick view
CDXS Revenue — quarterly 14.91M
CDXS Net income — quarterly -12.01M
CDXS EPS — quarterly -0.13
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 31, 2024 | Sep 1, 2024 | -0.25 | -0.29 | -0.04 | -16.00% |
| Aug 8, 2024 | Jun 1, 2024 | -0.26 | -0.32 | -0.06 | -23.08% |
| May 2, 2024 | Mar 1, 2024 | -0.17 | -0.16 | +0.01 | +5.88% |
| Feb 28, 2024 | Dec 1, 2023 | -0.16 | 0.02 | +0.18 | +112.50% |
| Nov 2, 2023 | Sep 1, 2023 | -0.32 | -0.26 | +0.06 | +18.75% |
| Aug 3, 2023 | Jun 1, 2023 | -0.21 | -0.17 | +0.04 | +19.05% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Nov 15, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Nov 4, 2024 | Benchmark | reit | — | Hold |
| Sep 20, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 29, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
| Aug 19, 2024 | Benchmark | down | Buy | Hold |
About Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- codexis.com
News
- Codexis to Report Third Quarter 2026 Financial Results on November 12
- Codexis Enters Agreement With An Unnamed siRNA Drug Innovator To Explore Stereo-Defined Fragment Synthesis Using Its ECO Synthesis Manufacturing Platform
- Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA
- Reviewing Codexis (NASDAQ:CDXS) & Revvity (NYSE:RVTY)
- Analyzing Codexis (NASDAQ:CDXS) and Mettler-Toledo International (NYSE:MTD)
- BlackRock Inc. Makes New Investment in Codexis, Inc. $CDXS
- Codexis to Participate in Cantor Global Healthcare Conference 2026
- Piper Sandler Maintains Overweight on Codexis, Lowers Price Target to $8
- Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
- Codexis, Inc. (CDXS) Q2 2026 Earnings Call Transcript
Your note
Sign in to keep a note on CDXS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DE VRE RAYMOND | Director | Stock Award(Grant) | Nov 6, 2024 | 47,846 |
| DORGAN BYRON L | Director | Stock Award(Grant) | Jun 10, 2024 | 223,581 |
| ERBEZ GEORGIA L | Chief Financial Officer | Stock Award(Grant) | Oct 9, 2024 | 50,000 |
| MARTINBOROUGH ESTHER | Director | Stock Award(Grant) | Jun 10, 2024 | 88,053 |
| MOORE ALISON | Chief Technology Officer | Stock Award(Grant) | Oct 9, 2024 | 148,696 |
| OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Oct 24, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Opaleye Management Inc. | 10.78% | 8,770,000 | 43.24M | Sep 29, 2024 |
| Casdin Capital, LLC | 9.95% | 8,100,000 | 39.93M | Sep 29, 2024 |
| Blackrock Inc. | 8.50% | 6,915,734 | 34.09M | Sep 29, 2024 |
| FMR, LLC | 5.53% | 4,497,090 | 22.17M | Sep 29, 2024 |
| Vanguard Group Inc | 5.10% | 4,152,719 | 20.47M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 3.65% | 2,967,808 | 14.63M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.55% | 2,075,798 | 10.23M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.23% | 1,811,668 | 8.93M | Oct 30, 2024 |
| Columbia Fds Ser Tr I-Columbia Small Cap Value Fd I | 1.56% | 1,267,085 | 6.25M | Jul 30, 2024 |
| Variable Insurance Products Fund-Growth Portfolio | 1.40% | 1,141,000 | 5.63M | Oct 30, 2024 |
| Fidelity Advisor Equity Growth Fund | 1.38% | 1,122,880 | 5.54M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.25% | 1,016,202 | 5.01M | Sep 29, 2024 |